BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31934209)

  • 1. Eukaryotic initiation factor 3B downregulation suppresses cell proliferation, migration and invasion while it induces cell apoptosis by blocking the β-catenin pathway in endometrial cancer.
    Min J; Chen H
    Int J Clin Exp Pathol; 2019; 12(9):3595-3603. PubMed ID: 31934209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eukaryotic translation initiation factor 3B downregulation inhibits cell proliferation and promotes cell apoptosis through negatively regulating tumor necrosis factor receptor superfamily member 21 in gastric cancer.
    Xiong H; Hu M; Huang H; Gong J; Wu J; Zhang H
    Transl Cancer Res; 2019 Oct; 8(6):2242-2251. PubMed ID: 35116977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of eukaryotic translation initiation factor 3 subunit B inhibits cell proliferation and migration and promotes apoptosis by downregulating WNT signaling pathway in acute myeloid leukemia.
    Feng Y; Wu L
    Int J Clin Exp Pathol; 2020; 13(1):99-106. PubMed ID: 32055278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of eukaryotic initiation factor 3B suppresses proliferation and promotes apoptosis of chronic myeloid leukemia cells.
    Huang L; He K; Wang J; Yan J; Jiang Y; Wei Z; Zhang J; Li G; Sheng L
    Adv Clin Exp Med; 2019 Dec; 28(12):1639-1645. PubMed ID: 31778600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of EIF3B gene downregulation on apoptosis and proliferation of human ovarian cancer SKOV3 and HO-8910 cells.
    Wang L; Ouyang L
    Biomed Pharmacother; 2019 Jan; 109():831-837. PubMed ID: 30551537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eukaryotic initiation factor 3b regulates the development and progression of breast cancer.
    Li Y; Zhao J; Yuan Z; Yuan D; Fang M; Xie M; Xia M
    Am J Cancer Res; 2023; 13(5):2188-2200. PubMed ID: 37293180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC-1A cells by the inhibition of the PI3K/Akt/mTOR pathway.
    Qu J; Sun Y; Yang L; Niu X; Li L
    J Biochem Mol Toxicol; 2022 Jun; 36(6):e23027. PubMed ID: 35266250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells.
    Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y
    Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.
    Zang Y; Zhang X; Yan L; Gu G; Li D; Zhang Y; Fang L; Fu S; Ren J; Xu Z
    J Cancer; 2017; 8(15):3049-3061. PubMed ID: 28928896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
    Zhang S; Wang M; Li Q; Zhu P
    Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of lncRNA-UCA1 targeting miR-204-5p on the proliferation, migration, apoptosis and immune escape of endometrial carcinoma cells].
    Jing S; Feng Y; He XL; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):56-63. PubMed ID: 36709121
    [No Abstract]   [Full Text] [Related]  

  • 13. Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells.
    Liang H; Ding X; Zhou C; Zhang Y; Xu M; Zhang C; Xu L
    Neurol Sci; 2012 Oct; 33(5):1057-62. PubMed ID: 22234522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA RHPN1-AS1 promotes the progression of endometrial cancer through the activation of ERK/MAPK pathway.
    Zhang XJ; Qi GT; Zhang XM; Wang L; Li FF
    J Obstet Gynaecol Res; 2021 Feb; 47(2):533-543. PubMed ID: 33169491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cells.
    Li J; Sun H; Liu T; Kong J
    Exp Ther Med; 2018 Nov; 16(5):4213-4224. PubMed ID: 30344696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
    Long P; Sun F; Ma Y; Huang Y
    Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression].
    Xiao L; Yang YB; Shen HM; Xu CF; Wang XY; Li XM
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):681-5. PubMed ID: 20079181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
    Hevir-Kene N; Rižner TL
    Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
    Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
    Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of YKL-40 gene RNA interference on the biological behaviors of endometrial cancer HEC-1A cells.
    Li L; Fan J; Li D; Liu Y; Shrestha P; Zhong C; Xia X; Huang X
    Oncol Lett; 2018 Aug; 16(2):1777-1784. PubMed ID: 30008865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.